Your browser doesn't support javascript.
loading
Safety and immunogenicity of MVC-COV1901 vaccine in older adults: Phase 2 randomized dose-comparison trial.
Waits, Alexander; Chen, Jau-Yuan; Cheng, Wei-Hong; Yeh, Jih-I; Hsieh, Szu-Min; Chen, Charles; Janssen, Robert; Lien, Chia En; Lin, Tzou-Yien.
Afiliação
  • Waits A; Medigen Vaccine Biologics Corporation, Taipei, Taiwan; Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chen JY; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Family Medicine, Chang Gung Memorial Hospital Linkou Branch, Taoyuan City, Taiwan.
  • Cheng WH; Department of Hematology and Oncology, Cancer Center, Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan.
  • Yeh JI; Department of Family Medicine, Hualien Tzu Chi Hospital, Hualien County, Taiwan.
  • Hsieh SM; Department of Internal Medicine, Division of Infectious Diseases, National Taiwan University Hospital, Taipei City, Taiwan.
  • Chen C; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Janssen R; Dynavax Technologies Corporation, Emeryville, CA 94608, U.S.A.
  • Lien CE; Medigen Vaccine Biologics Corporation, Taipei, Taiwan; Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan. Electronic address: Allenlien@medigenvac.com.
  • Lin TY; Department of Pediatrics, Chang Gung Memorial Hospital Taoyuan Branch, Taoyuan City, Taiwan. Electronic address: Alinpid@gmail.com.
Int J Infect Dis ; 124: 21-26, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36049700
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article